首页 | 本学科首页   官方微博 | 高级检索  
检索        

川芎嗪洗脱支架预防支架内再狭窄的实验研究
引用本文:李璇,陈忠,马根山,苏亚民,顾兴中.川芎嗪洗脱支架预防支架内再狭窄的实验研究[J].东南大学学报(医学版),2008,27(2):102-105.
作者姓名:李璇  陈忠  马根山  苏亚民  顾兴中
作者单位:1. 东南大学,临床医学院,江苏,南京,210009
2. 东南大学,机械工程学院,江苏,南京,210096
基金项目:江苏省社会发展基金资助项目(BS204026)
摘    要:目的:研究川芎嗪洗脱支架(TES)抑制内膜增生防治再狭窄的效果及其机制。方法:小型猪9只随机分为3组,实验组植入TES(TES组),对照组植入金属裸支架(BMS组)或雷帕霉素洗脱支架(SES组)。术后第28天处死动物,组织病理学检测内膜厚度,免疫组织化学法测定增殖细胞核抗原(PCNA),TUNEL法测细胞凋亡,扫描电镜观察内皮细胞的覆盖情况。结果:术后第28天病理学证实,TES组较BMS组管腔面积增加、支架内新生内膜面积和面积再狭窄百分比减小(P<0.05)。BMS组较TES组PCNA细胞阳性率明显增加(P<0.05),TES组较SES组PCNA阳性率增加(P<0.05)。TES组较BMS组单位面积内平滑肌细胞(VSMC)凋亡数明显增加(P<0.05)。扫描电镜显示TES组和BMS组28 d血管内皮细胞完全覆盖,SES组基本覆盖,但内膜不平整。结论:TES可以显著抑制VSMC增殖、迁移并促进VSMC凋亡,但不影响血管内皮愈合,是防治血管再狭窄的新策略。

关 键 词:川芎嗪  药物洗脱支架  再狭窄  免疫组织化学
文章编号:1671-6264(2008)02-0102-04
修稿时间:2007年7月4日

Experimental study of preventive effect of tetramethylpyrazine-eluting stents on in-stent restenosis
LI Xuan,CHEN Zhong,MA Gen-shan,SU Ya-min,GU Xing-zhong.Experimental study of preventive effect of tetramethylpyrazine-eluting stents on in-stent restenosis[J].Journal of Southeast Univ: Medical Sci Ed,2008,27(2):102-105.
Authors:LI Xuan  CHEN Zhong  MA Gen-shan  SU Ya-min  GU Xing-zhong
Abstract:Objective To assess the preventive effect and mechanism of tetramethylpyrazine(TMP)-eluting stents(TES)on in-stent restenosis in pigs.Methods Nine pigs were randomly divided into TES group,bare-metal stents(BMS) group and sirolimus-eluting stents(SES) group.The TES group was implanted with TES,the BMS group with BMS,the SES group with SES.At the 28th day,animals were executed and neointimal thicknesses,proliferating cell nuclear antigen(PCNA) of vascular smooth muscle cell(VSMC),apoptosis of VSMC were measured.Scan electron microscope was used to observe the covering instances of endothelial cells.Results Comparing with BMS,luminal area was significantly increased in the TES group(P<0.05),while neointimal area and percentage of restenosis were significantly decreased in the TES group(P<0.05).The positive ratio of PCNA of BMS group was higher than that of TES group(P<0.05).The positive ratio of PCNA of TES group was higher than that of SES group.The apoptosis was significantly increased in TES group than that in BMS group(P<0.05).Scan electron microscope indicated complete reendothelialization at the 28th day in BMS and TES groups,but poor endothelium covering in the SES group.Conclusion TES can inhibit the hyperplasia and migration of VSMC and increase VSMC apoptosis,but it has no effect on the healing of endothelium.TES is a promising and new strategy in preventing restenosis.
Keywords:tetramethylpyrazine  drug-eluting stent  restenosis  immunohistochemistry
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号